Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Storb

Showing results (831-840 of 899) with videos related to

Pageof 90
Sort By:
Blood|August 10, 1999
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndromeD C Matthews, F R Appelbaum, J F Eary, et al.
Blood|July 1, 1974
Treatment of established human graft-versus-host disease by antithymocyte globulinR Storb, E Gluckman, E D Thomas, et al.
Transactions of the Association of American Physicians|January 1, 1971
Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairsE D Thomas, J I Bryant, C D Buckner, et al.
British Journal of Haematology|February 24, 2005
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioningJ P Panse, S Heimfeld, K A Guthrie, et al.
Transplantation|May 1, 1973
Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantationP Neiman, P B Wasserman, B B Wentworth, et al.
Blood|September 25, 1999
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipientsP J Martin, S D Rowley, C Anasetti, et al.
Blood|June 22, 2001
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphismC M Ulrich, Y Yasui, R Storb, et al.
Blood|May 1, 1983
Fanconi's anemia treated by allogeneic marrow transplantationH J Deeg, R Storb, E D Thomas, et al.
Leukemia|June 4, 2014
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantationR B Walter, B Gyurkocza, B E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2001
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centersR Storb, K G Blume, M R O'Donnell, et al.
Pageof 90

Showing results (831-840 of 899) with videos related to

Sort By:
Pageof 90
Blood|August 10, 1999
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndromeD C Matthews, F R Appelbaum, J F Eary, et al.
Blood|July 1, 1974
Treatment of established human graft-versus-host disease by antithymocyte globulinR Storb, E Gluckman, E D Thomas, et al.
Transactions of the Association of American Physicians|January 1, 1971
Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairsE D Thomas, J I Bryant, C D Buckner, et al.
British Journal of Haematology|February 24, 2005
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioningJ P Panse, S Heimfeld, K A Guthrie, et al.
Transplantation|May 1, 1973
Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantationP Neiman, P B Wasserman, B B Wentworth, et al.
Blood|September 25, 1999
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipientsP J Martin, S D Rowley, C Anasetti, et al.
Blood|June 22, 2001
Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphismC M Ulrich, Y Yasui, R Storb, et al.
Blood|May 1, 1983
Fanconi's anemia treated by allogeneic marrow transplantationH J Deeg, R Storb, E D Thomas, et al.
Leukemia|June 4, 2014
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantationR B Walter, B Gyurkocza, B E Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2001
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centersR Storb, K G Blume, M R O'Donnell, et al.
Pageof 90